0.45
前日終値:
$0.418
開ける:
$0.423
24時間の取引高:
830.55K
Relative Volume:
0.07
時価総額:
$9.71M
収益:
$414.60K
当期純損益:
$-19.21M
株価収益率:
-0.2777
EPS:
-1.6207
ネットキャッシュフロー:
$-4.89M
1週間 パフォーマンス:
+1.24%
1か月 パフォーマンス:
+9.49%
6か月 パフォーマンス:
+17.19%
1年 パフォーマンス:
-82.49%
Mangoceuticals Inc Stock (MGRX) Company Profile
名前
Mangoceuticals Inc
セクター
電話
(833) 626-4679
住所
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX vs VEEV, TEM, BTSG, TXG, HNGE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
MGRX
Mangoceuticals Inc
|
0.45 | 10.05M | 414.60K | -19.21M | -4.89M | -1.6207 |
|
VEEV
Veeva Systems Inc
|
283.50 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
71.98 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
63.75 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TXG
10 X Genomics Inc
|
80.66 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
|
HNGE
Hinge Health Inc
|
98.35 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Mangoceuticals Inc (MGRX) 最新ニュース
Mangoceuticals Secures Strategic Investment in MangoRx IP Subsidiary - TipRanks
Form 8K Mangoceuticals Inc For: 1 October By Investing.com - Investing.com Canada
Mangoceuticals Announces $2.5 Million Subsidiary-Level Investment in MangoRx IP Holdings to Advance Antiviral Portfolio Commercialization - Quiver Quantitative
Mangoceuticals subsidiary secures $2.5M investment By Investing.com - Investing.com UK
Investors agreed to buy 25% of Mangoceuticals’ company holding antiviral patents for $2.5 million. - Stock Titan
Mangoceuticals Q3 2025 Earnings: Loss Per Share of $0.69 as Shares SlipShare Repurchase Impact - careplusvn.com
MGRX Q3 2025 Earnings: Per-Share Loss of $0.69 as Shares Slip 4%Margin Guidance - dars.gov.et
Mangoceuticals Terminates Planned Business Combination with Nuclea - The Globe and Mail
Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19 - TradingView
Mangoceuticals Terminates Nuclea Energy Business Combination After $15 Million PIPE Not Secured - TradingView
Mangoceuticals Company Profile & Introduction - Moomoo
MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders - businesswire.com
MANGOCEUTICALS, INC. Q2 2026: Revenue $68.76K, EPS $(0.09) — 10-Q Summary - TradingView
Mangoceuticals (MGRX) Q2 2026 loss shrinks while cash and revenue fall - Stock Titan
Mangoceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
12 Consumer Staples Stocks Moving In Thursday's After-Market Session - Benzinga
Mangoceuticals: Acquisition of Moltex Brings Advanced Nuclear R&D, Backed by More Than C$96M in Private Investment and Public Funding From Canada and the DOE >MGRX - Moomoo
Nuclea’s planned Moltex deal could add 80 nuclear patents - Stock Titan
Mangoceuticals (MGRX) Earnings Date and Reports 2026 - MarketBeat
MGRX Q3 2025 Earnings: -$0.69 Per Share Loss and 8.16% Stock Decline Highlight Ongoing ChallengesNext Quarter Guidance - dars.gov.et
Why is Mangoceuticals stock surging today? - Investing.com India
On Thursday, there are stocks with unusual volume. Let's take a look. - ChartMill
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com South Africa
Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - The Manila Times
Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU With New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - Moomoo
Mangoceuticals (MGRX) merger partner Nuclea inks Utah nuclear test reactor MOU - Stock Titan
Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - Benzinga
Mangoceuticals merger partner Nuclea signs MOU with New Mining on modular reactor power for data centers - Bitget
Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - The Globe and Mail
Wondering what's happening in today's after-hours session? - ChartMill
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - Yahoo Finance
Mangoceuticals (NASDAQ: MGRX) wins more time on Nasdaq rules, advances Nuclea deal - Stock Titan
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - The Manila Times
Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesSmart Money Flow Stocks - dars.gov.et
$Mangoceuticals (MGRX.US)$ - Moomoo
MGRX Q3 2025 Earnings: Reported EPS of -$0.69 as Shares Rally 89.75%Positive Surprise Momentum - careplusvn.com
Mangoceuticals, Inc. Common Stock (NASDAQ: MGRX) Stock Price, News & Analysis - Kalkine
Microcaps MGRX, PRSO, IGC, KUST In the News to Watch - openPR.com
That’s quite fortunate! - Moomoo
$Mangoceuticals (MGRX.US)$ wow finally CB ⬆️ [Grin][Drool][Cool Guy][Angry][Tongue] - moomoo.com
$Mangoceuticals (MGRX.US)$ sold a tad early. but definitely looking for another entry! - Moomoo
Form 4 Mangoceuticals Inc For: 30 July By Investing.com - Investing.com Canada
Nuclea Energy to go public via merger with Mangoceuticals By Investing.com - Investing.com Nigeria
Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - TMX Newsfile
Nuclea Energy Inc: Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - FinanzNachrichten.de
Mangoceuticals agrees to merge with nuclear microreactor developer - Investing.com Nigeria
Mangoceuticals agrees to merge with nuclear microreactor developer By Investing.com - Investing.com Canada
Jacob D. Cohen to Leave CEO Role at Mangoceuticals, Becomes President in Consulting Role - TradingView
Mangoceuticals Announces Nuclea Energy Business Combination Agreement - TipRanks
Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mangoceuticals Inc (MGRX) 財務データ
収益
当期純利益
現金流量
EPS
Mangoceuticals Inc (MGRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| JOHNSTON EUGENE M | CFO |
Dec 09 '25 |
Sale |
1.20 |
5,000 |
5,975 |
123,333 |
| JOHNSTON EUGENE M | CFO |
Dec 05 '25 |
Sale |
1.13 |
10,000 |
11,280 |
128,333 |
大文字化:
|
ボリューム (24 時間):